Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0000899140-25-001459

Director bought 46,141 shares at an average $11.68 ($538,972)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-18 Purchase +8,700 $11.24 $97,788 9,546,875 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-18 Purchase +1,515 $11.24 $17,029 1,821,327 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-19 Purchase +13,950 $11.48 $160,146 9,560,825 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-19 Purchase +2,434 $11.48 $27,942 1,823,761 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-22 Purchase +16,650 $12.08 $201,132 9,577,475 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2025-12-22 Purchase +2,892 $12.08 $34,935 1,826,653 I
Open-market purchases · 46,141 sh · avg $11.68 · $538,972
Loading xslF345X05/form4.xml…